Home LiteratureArticle Details
PMID: 8314771 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.

The Journal of biological chemistry ·Vol. 268 ·No. 19 ·1993-07-05 ·Pages 14033-9

Strongin AY, Marmer BL, Grant GA, Goldberg GI

Abstract

Human 72-kDa type IV collagenase (72T4Cl) is secreted as a proenzyme that can form a specific stoichiometric complex with the tissue inhibitor of metalloproteases TIMP-2 via interaction with the carboxyl-terminal domain of the enzyme. Both complexed and free enzymes can be activated by treatment with organomercurials. The mechanism of the 72T4Cl activation under physiological conditions is not known. Here we describe a "plasma membrane-dependent" activation of inhibitor-free 72T4Cl and identify the first conversion intermediate as a 64-kDa species resulting from cleavage of the Asn37-Leu peptide bond in the presence of plasma membranes from 12-O-tetradecanoylphorbol-13-acetate-induced HT1080 cells. This reaction is specific for 72T4Cl in that a closely related proenzyme (92-kDa type IV collagenase) is resistant to activation under the same conditions. Formation of the 72T4Cl.TIMP-2 complex inhibits activation at the level of the initial Asn37-Leu cleavage. Addition of TIMP-1 has no effect on this reaction, but blocks the autocatalytic conversion of the Leu38 intermediate into a 62-kDa active enzyme with an amino-terminal Tyr81. Membrane-dependent activation of 72T4Cl is competitively inhibited in the presence of a 26-kDa peptide derived from the carboxyl-terminal domain of the enzyme. The results suggest that interaction of the carboxyl-terminal domain of the enzyme with a membrane-associated component(s) causes initiation of enzyme activation through an autoproteolytic mechanism.

MeSH Terms
Amino Acid Sequence Cell Membrane/metabolism Chromatography, Gel Collagenases/isolation & purification,metabolism Cyanogen Bromide Enzyme Activation Enzyme Precursors/isolation & purification,metabolism Fibrosarcoma Humans Matrix Metalloproteinase Inhibitors Molecular Sequence Data Neoplasm Proteins/isolation & purification,metabolism,pharmacology Peptide Fragments/isolation & purification,metabolism Tissue Inhibitor of Metalloproteinase-2 Tumor Cells, Cultured
Chemicals
Enzyme Precursors Matrix Metalloproteinase Inhibitors Neoplasm Proteins Peptide Fragments Tissue Inhibitor of Metalloproteinase-2 Collagenases procollagenase Cyanogen Bromide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Strongin A Y
Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110-1093.
Marmer B L
Grant G A
Goldberg G I
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1993-07-05
Pages
14033-9
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NIAMS NIH HHS · R01 AR39472 · United States
NIAMS NIH HHS · R01 AR40618 · United States
NIAMS NIH HHS · T32 AR07284 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]